- Home
- ARBK vs EDSA Comparison
ARBK vs EDSA Comparison
Compare ARBK & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBK
- EDSA
- Stock Information
- Founded
- ARBK 2017
- EDSA 2015
- Country
- ARBK United Kingdom
- EDSA Canada
- Employees
- ARBK N/A
- EDSA N/A
- Industry
- ARBK Finance: Consumer Services
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- ARBK Finance
- EDSA Health Care
- Exchange
- ARBK Nasdaq
- EDSA Nasdaq
- Market Cap
- ARBK 18.6M
- EDSA 17.2M
- IPO Year
- ARBK 2021
- EDSA N/A
- Fundamental
- Price
- ARBK $0.27
- EDSA $2.30
- Analyst Decision
- ARBK Hold
- EDSA Strong Buy
- Analyst Count
- ARBK 1
- EDSA 2
- Target Price
- ARBK N/A
- EDSA $13.00
- AVG Volume (30 Days)
- ARBK 1.2M
- EDSA 12.0K
- Earning Date
- ARBK 09-04-2025
- EDSA 08-08-2025
- Dividend Yield
- ARBK N/A
- EDSA N/A
- EPS Growth
- ARBK N/A
- EDSA N/A
- EPS
- ARBK N/A
- EDSA N/A
- Revenue
- ARBK $47,017,000.00
- EDSA N/A
- Revenue This Year
- ARBK $183.90
- EDSA N/A
- Revenue Next Year
- ARBK $26.78
- EDSA N/A
- P/E Ratio
- ARBK N/A
- EDSA N/A
- Revenue Growth
- ARBK N/A
- EDSA N/A
- 52 Week Low
- ARBK $0.15
- EDSA $1.55
- 52 Week High
- ARBK $1.55
- EDSA $5.00
- Technical
- Relative Strength Index (RSI)
- ARBK 47.17
- EDSA 43.90
- Support Level
- ARBK $0.25
- EDSA $2.41
- Resistance Level
- ARBK $0.30
- EDSA $2.47
- Average True Range (ATR)
- ARBK 0.02
- EDSA 0.07
- MACD
- ARBK 0.00
- EDSA -0.02
- Stochastic Oscillator
- ARBK 53.00
- EDSA 0.00
About ARBK Argo Blockchain plc
Argo Blockchain PLC is a blockchain technology company focused on the large-scale mining of Bitcoin. It mines bitcoin using purpose-built computers (or mining machines) to solve complex cryptographic algorithms on the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company acquires and deploys mining technology solutions in North American facilities that utilize predominantly renewable and inexpensive electricity.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.